Two classes of trisubstituted pyrimidines related to PI-103 1 have been prepared and their inhibitory activities against phosphatidylinositol 3-kinase (PI3K) p110α were determined. From those with direct 6-aryl substitution compound 11a was the most potent inhibitor with an IC₅₀ value of 62 nM, and showed similar activity against other class 1a PI3K isoforms tested, p110β and p110γ. When a linking chain was introduced, as in the second exemplified class, compound 15f inhibited p110α with IC₅₀ 142 nM, and showed greater selectivity towards p110α. Compounds of both classes showed promising inhibition of cellular proliferation in IGROV-1 ovarian cancer cells. Among compounds designed to replace the 3-phenolic motif with structural isosteres, analogues incorporating a 4-indazolyl group possessed enzyme and cellular activities comparable to the parent phenols.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2010.12.006DOI Listing

Publication Analysis

Top Keywords

trisubstituted pyrimidines
8
phosphatidylinositol 3-kinase
8
preparation evaluation
4
evaluation trisubstituted
4
pyrimidines phosphatidylinositol
4
3-kinase inhibitors
4
inhibitors 3-hydroxyphenol
4
3-hydroxyphenol analogues
4
analogues bioisosteric
4
bioisosteric replacements
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!